News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Biotron.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX’s September Shocker ends on a win as uranium spot clocks 15-yr high
News
ASX Small Caps and IPO Weekly Wrap: Things went better than expected in a week all about lithium and uranium
News
ASX Small Caps Lunch Wrap: Who’s marking the end of a home-delivered era today?
News
Top 10 at 11: It’s a mixed up kinda morning, but we’re moving in the right direction… for now
Health & Biotech
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Local markets fall on timid Tuesday but Biotron bets build as investors ask if it’s aced an anti-viral AIDS therapy
News
In Case You Missed It: Visual spodumene and Covid clinical trials
Health & Biotech
ASX Health Stocks: Weed stock Epsilon sees growing demand for cannabis, gets licence renewal in Australia
News
Closing Bell: Crash, what crash? Small caps walk away unhurt as ASX 200 bleeds 2.6%; AQC jumps a gazillion again
Health & Biotech
ASX Health Stocks: Biotron expands COVID-19 study in Thailand; Noxopharm, Clarity progress pancreatic cancer research
News
Top 10 at 10: Which ASX stocks are on the gain train this morning?
News
Closing Bell: Hands up if you’re an ex-PM about to be sued by BPH Energy, which has gained 235% today on the very prospect of it
Health & Biotech
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022
News
Closing Bell: Thank heavens for the earth, as miners and metals keep everything afloat
Health & Biotech
